期刊文献+

药物洗脱支架治疗椎基底动脉狭窄 被引量:8

Drug-eluting stent implantation for the percutaneous treatment of vertebro-basilar arterial stenosis
暂未订购
导出
摘要 目的总结应用药物洗脱支架治疗椎基底动脉狭窄的经验,探讨其近、中期疗效、安全性及预防再狭窄的作用。方法27例患者均为反复短暂性脑缺血发作(TIA)或脑梗死后恢复良好,狭窄程度在50%以上且常规药物治疗无效。在局麻或全麻下,采用直接支架成形术进行治疗。术后常规给予抗血小板聚集治疗,并定期进行临床和影像学随访。结果27例患者28处脑动脉狭窄采用药物洗脱支架进行治疗,其中27处成功植入药物洗脱支架(Cypher支架24枚,Taxus支架2枚,Firebird支架1枚)。平均狭窄程度从术前(74.5±6.7)%减少到(8.7±4.4)%。2例发生穿支血管闭塞症状。术后临床随访2~14个月,无一例患者出现TIA或卒中复发。14例患者接受血管造影随访,随访时间为3~18个月,1例支架近端狭窄(<50%),无一例支架内再狭窄。结论短期结果显示应用药物洗脱支架治疗脑供血动脉狭窄是安全和有效的,但长期疗效有待于进一步观察。 Objective To evaluate the early results and mid-term outcomes following angioplasty of vertebro-basilar arterial stenosis with drug-eluting stents. Methods All of the patients presented with recurrent TIA or ceretral infarction with 〉 50% stenoses in vertebro-basilar arteries, and having failure in maximal medical therapy. All of the lesions were treated with primary stenting under local or general anesthesia and followed by continual anticoagulant therapy of clopidogrel and aspirin together with clinical follow-up and vascular imagings. Results Of 28 stenoses (27 patients), 27 lesions were successfully treated with implantation of 24 Cypher stents, 2 Taxus stents and one Firebird stent. The mean stenotic severity reduced from (74 ± 6.7)% to (8.7 ± 4.4)%. Two patients had inchemic events relating to penetration vascular obstruction. During 2- 14 months follow-up, the patients were clinically asymptomatic with no recurrent TIA/ stoke. Angiographic follow-up was obtained in 14 patients at a mean of 7.2 months. Proximal restenosis(〈 50%) occurred in one patient(3.3%), and corrected with restenting, while others were free of intra-stent restenoses. Conclusion Using DES in cerebrovascular stenosis is safe and effective with lowing the risk of intra-stent restenosis in comparison with bare stent. Further study for long term efficiency is still in need.
出处 《介入放射学杂志》 CSCD 2006年第11期643-647,共5页 Journal of Interventional Radiology
关键词 脑缺血 支架成形术 介入 Cerebral ischemia Angioplasy Intervention
  • 相关文献

参考文献13

  • 1刘建民,洪波,黄清海,许奕,赵文元,张珑,赵瑞,周晓平.支架成形术治疗颅内血管狭窄的安全性及短期疗效分析[J].中华外科杂志,2004,42(3):169-172. 被引量:27
  • 2Jiang Weijian,Wang Yongjun,Du Bin,et al.Stenting of symptomatic M1 stenosis of middle cerebral artery:An initial experience 40 patients[J].Stroke,2004,35:1375-1380.
  • 3The SSYLVIA study investigators.Stenting of symptomatic atherosclerotic lesions in the vertebral or intracranial arteries (SSYLVIA):study results[J].Stroke,2004,35:1388-1392.
  • 4Holmes DR Jr,Leon MB,Moses JW,et al.Analysis of 1-year clinical outcomes in the SIRIUS trial:a randomized trial of a sirolimus-eluting stent versus a standard stent in patients at high risk for coronary restenosis[J].Circulation,2004,109:634 -640.
  • 5Wong KS,Huang YN,Gao S,et al.Cerebrovascular disease among Chinese populations-recent epidemiological and neuroimaging studies[J].HKMJ,2001,7:50-57.
  • 6史怀璋,李斗,李慎茂,凌锋.经DSA分析1000例缺血性脑血管病华人患者的病因特点[J].中国脑血管病杂志,2005,2(10):437-440. 被引量:93
  • 7The EC/IC bypass study group.Failure of extracranial intracranial artery bypass to reduced the risk of ischemic stroke:results of an international randomized trial-The EC/IC bypass study group[J].N Engl J Med,1985,313:1191-1200.
  • 8Sundt TM Jr,Smith HC,Campbell JK,et al.Transluminal angioplasty for basilar artery stenosis[J].Mayo Clin Proc,1980,55:673-680.
  • 9Ko YG,Park S,Kim JY,et al.Percutaneous interventional treatment of extracranial vertebral artery stenosis with coronary stents[J].Yonsei Med J,2004,45,:629-634.
  • 10Lowe HC,Oesterle SN,Khachigian LM.Cornary in-stent restenosis:current status and future strategies[J].J Am Coll Cardiol,2002,39:183-193.

二级参考文献12

  • 1冯烈,徐安定,李洁.经颅多普勒超声对糖尿病患者脑血管病变的诊断价值[J].中华内分泌代谢杂志,1994,10(2):86-88. 被引量:115
  • 2[1]Wong KS. Is the measurement of cerebral microembolic signals a good surrogate marker for evaluating the efficacy of antiplatelet agents in the prevention of stroke.? Eur Neurol,2005, 53: 132-139.
  • 3[2]Sacco RL, Kargman DE, Gu Q, et al. Race-ethnicity and determinants of intracranial atherosclerotic cerebral infarction. Stroke, 1995, 26: 14-20.
  • 4[3]Frey J, Jahnke H, Bulfinch E. Difference in stroke between White, Hispanic and Native American patients.Stroke, 1998, 29: 29-33.
  • 5[4]Feldmann E, Daneault N, Kwan E, et al. Chinese-White differences in the distribution of occlusive cerebrovascular disease. Neurology, 1990, 47: 1080-1084.
  • 6[6]Huang YN, Gao S, Huang Y, et al. Vascular lesion in Chinese patients with transient ischemic attacks. Neurology,1997, 48: 524-525.
  • 7[7]Wong KS, Gao S, Lam W, et al. A pilot study of microembolic signals in patients with middle cerebral artery stenosis. J Neuroimaging, 2001, 11: 137-140.
  • 8[8]Wald DS, Law M, Morris JK. Homocysteine and cardiovascular disease: evidence on causality from a meta analysis. BMJ, 2002, 325: 73-74.
  • 9[9]Smith C J, Emsley HC, Gavin CM, et al. Peak plasma interleukin-6 and other peripheral markers of inflammation in the first week of ischaemic stroke correlate with brain infarct volume, stroke severity and long-term outcome. BMC Neurol, 2004, 15: 2.
  • 10[10]Nagano K, Otsubo R, Yasaka M, et al. Stroke recurrence in patients with brain embolism and patent foramen ovaleassociation with deep vein thrombosis detected by ultrasonography. Rinsho-Shinkeigaku, 2004, 44: 7-13.

共引文献118

同被引文献109

引证文献8

二级引证文献38

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部